CLARUS THERAPEUTICS HOLDINGS, INC. Shareholders' Equity
CLARUS THERAPEUTICS HOLDINGS, INC. had Shareholders' Equity of -$13.06 million as of 2022-06-30, per its 10-Q filed 2022-08-19.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2022-08-19
- 2022-06-30: Stockholders' Equity Attributable to Parent -$13.06M.
- 2022-03-31: Stockholders' Equity Attributable to Parent -$30.36M.
- 2021-12-31: Stockholders' Equity Attributable to Parent -$15.92M.
- 2021-09-30: Stockholders' Equity Attributable to Parent -$25.52M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2022-06-30 | -$13.06M 10-Q · filed 2022-08-19 | |
| 2022-03-31 | -$30.36M 10-Q · filed 2022-08-19 | |
| 2021-12-31 | -$15.92M 10-Q · filed 2022-08-19 | |
| 2021-09-30 | -$25.52M 10-Q · filed 2021-11-19 | |
| 2021-06-30 | -$354.88M 10-Q · filed 2022-08-19 | $5.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$333.14M 10-Q · filed 2022-08-19 | $5.00M 10-Q · filed 2021-05-26 |
| 2020-12-31 | -$325.78M 10-Q · filed 2022-08-19 | $5.00M 10-K · filed 2021-05-06 |
| 2020-09-30 | -$128.45M 10-Q · filed 2021-11-19 | |
| 2020-06-30 | -$133.95M 10-Q · filed 2021-11-19 | $24.24K 10-Q · filed 2021-08-16 |
| 2020-03-31 | -$144.57M 10-Q · filed 2021-11-19 | |
| 2019-12-31 | -$316.27M 10-K · filed 2022-03-31 |